Replies to post #154027 on Biotech Values

[biomaven0]

>>projects "only" $1.25B breast-cancer sales for PD-991 in 2020

That's actually quite a bit lower than the potential Mark Schoenebaum sees - if I recall correctly he saw a potential for an unbelievable $4B or more, with $2B as his low range.

Peter